New Haven, CT – August 18, 2025 – Cogstate, a leading neuroscience technology company, today announced the appointment of Luka Lucić, PhD, as Senior Director, Clinical Science, Psychiatry. Dr. Lucić brings more than a decade of experience in psychiatric scale administration within global biopharmaceutical programs and extensive expertise in developing and leading clinical trial training initiatives across psychiatry, neurodevelopment, and rare disease indications.
In his new role, Dr. Lucić will lead endpoint management and data quality for global clinical trials in psychiatry and related CNS therapeutic areas. Drawing on his deep expertise in mood disorders and clinical research, he will help collaborate with biopharmaceutical teams to ensure Cogstate delivers the highest scientific standards and operational excellence.
“We are delighted to have Luka officially join our team,” said Pam Ventola, PhD, Chief Science Officer at Cogstate. “Having collaborated with him for many years, we’ve seen firsthand how his deep knowledge of psychiatric scales leads to thoughtful endpoint selection and how his innovative training approaches reduce rater burden and maximize retention. His expertise will be a vital asset to biopharmaceutical teams pursuing mood disorder research.”
“I’m thrilled to be joining a team filled with fellow scientists,” said Dr. Lucić. “I’ve seen the team at Cogstate consistently show its commitment to scientific rigor, operational efficiency and uncompromising quality. I am eager to be part of this work and share what I’ve learned to best support clinical trials advancements across psychiatric research.”
Dr. Lucić is an Associate Professor in the Department of Social Science and Cultural Studies at the Pratt Institute in Brooklyn, New York. He served on the Board of Directors of the Jean Piaget Society from 2017 to 2021 and was an Adult Literacy Fellow at New York City’s Office of the Mayor. He earned his PhD in Developmental Psychology from The City University of New York (CUNY).
###
